Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel C Mok

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
The Journal of Reproductive Medicine|June 18, 2002
Recent advances in molecular biology of gestational trophoblastic diseases. A reviewVilmos Fulop, Samuel C Mok, Istvan Gati, et al.
BMC Developmental Biology|August 6, 2008
Dynamic expression of Dab2 in the mouse embryonic central nervous systemKwok-Kuen Cheung, Samuel C Mok, Payam Rezaie, et al.
Gynecologic Oncology|November 18, 2005
PTEN expression in clear cell adenocarcinoma of the ovaryYasunori Hashiguchi, Hiroshi Tsuda, Takeshi Inoue, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|November 25, 2005
Low erythrocyte complement receptor type 1 (CR1, CD35) expression in preeclamptic gestationsBruce B Feinberg, Richard M Jack, Samuel C Mok, et al.
Cancers|February 22, 2018
Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated DecisionKelsey E Lewis, Karen H Lu, Amber M Klimczak, et al.
Anticancer Research|August 21, 2003
Expression of cytokines and receptors in normal, immortalized, and malignant ovarian epithelial cell linesChristina A Bandera, Hing Wo Tsui, Samuel C Mok, et al.
Scientific Reports|September 6, 2017
Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasisFatemeh Vafaee, Emily K Colvin, Samuel C Mok, et al.
Human Genetics|August 4, 2004
Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CNA) for oral premalignancy progression using the Affymetrix 10K SNP mapping arrayXiaofeng Zhou, Samuel C Mok, Zugen Chen, et al.
Disease Markers|December 7, 2007
Biomarkers of mucinous tumors of the ovaryGoli Samimi, Laurent Ozbun, Michael E Johnson, et al.
Cancer Genetics and Cytogenetics|May 4, 2004
Whole genome loss of heterozygosity profiling on oral squamous cell carcinoma by high-density single nucleotide polymorphic allele (SNP) arrayXiaofeng Zhou, Cheng Li, Samuel C Mok, et al.
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
The Journal of Reproductive Medicine|June 18, 2002
Recent advances in molecular biology of gestational trophoblastic diseases. A reviewVilmos Fulop, Samuel C Mok, Istvan Gati, et al.
BMC Developmental Biology|August 6, 2008
Dynamic expression of Dab2 in the mouse embryonic central nervous systemKwok-Kuen Cheung, Samuel C Mok, Payam Rezaie, et al.
Gynecologic Oncology|November 18, 2005
PTEN expression in clear cell adenocarcinoma of the ovaryYasunori Hashiguchi, Hiroshi Tsuda, Takeshi Inoue, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|November 25, 2005
Low erythrocyte complement receptor type 1 (CR1, CD35) expression in preeclamptic gestationsBruce B Feinberg, Richard M Jack, Samuel C Mok, et al.
Cancers|February 22, 2018
Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated DecisionKelsey E Lewis, Karen H Lu, Amber M Klimczak, et al.
Anticancer Research|August 21, 2003
Expression of cytokines and receptors in normal, immortalized, and malignant ovarian epithelial cell linesChristina A Bandera, Hing Wo Tsui, Samuel C Mok, et al.
Scientific Reports|September 6, 2017
Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasisFatemeh Vafaee, Emily K Colvin, Samuel C Mok, et al.
Human Genetics|August 4, 2004
Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CNA) for oral premalignancy progression using the Affymetrix 10K SNP mapping arrayXiaofeng Zhou, Samuel C Mok, Zugen Chen, et al.
Disease Markers|December 7, 2007
Biomarkers of mucinous tumors of the ovaryGoli Samimi, Laurent Ozbun, Michael E Johnson, et al.
Cancer Genetics and Cytogenetics|May 4, 2004
Whole genome loss of heterozygosity profiling on oral squamous cell carcinoma by high-density single nucleotide polymorphic allele (SNP) arrayXiaofeng Zhou, Cheng Li, Samuel C Mok, et al.
Pageof 15